e-learning
resources
ERJ
2003
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Levalbuterol toxicity: no reason to be jittery
Biswas A.K., Fruedenthal W.C.
Source:
Eur Respir J 2003; 21: 1081
Journal Issue:
June
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Biswas A.K., Fruedenthal W.C.. Levalbuterol toxicity: no reason to be jittery. Eur Respir J 2003; 21: 1081
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Cleaning agents: how they look like and how might they cause respiratory harm?
Source: International Congress 2018 – Cleaning agent exposures: are they really harmful to lung health?
Year: 2018
Marijuana and the lung: hysteria or cause for concern?
Source: Breathe, 14 (3) 196; 10.1183/20734735.020418
Year: 2018
Paracetamol use and the risk of wheeze: causation or bias?
Source: Annual Congress 2009 - Early life and childhood asthma - new results from old birth cohorts
Year: 2009
What is this thing called somnolence?
Source: Eur Respir J 2011; 37: 7-8
Year: 2011
Theophylline again? Reasons for believing
Source: Eur Respir J 2009; 34: 5-6
Year: 2009
The side-effects of TB therapy: myth and reality
Source: Annual Congress 2005 - PG10 - The management of tuberculosis: tradition and novelties
Year: 2005
Introducing a new formulation of pirfenidone to reduce tablet burden for the IPF patient: Is it tolerable? Is it easy to take? What do our patients think?
Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Year: 2018
LATE-BREAKING ABSTRACT: Tackling the burden of chronic cough: A dose escalation study of AF-219
Source: International Congress 2016 – Late-breaking topics in airways disease
Year: 2016
Breathlessness: respiratory, cardiac, or something else?
Source: International Congress 2015 – Primary Care Programme
Year: 2015
Residual excessive sleepiness in long term CPAP-treated patients: a leak problem?
Source: International Congress 2018 – New diagnostic tools for sleep and breathing and healthcare provision options
Year: 2018
Immunotherapy: when, who and which drug?
Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer
Year: 2018
Opioids in COPD: a cause of death or a marker of illness severity?
Source: Eur Respir J 2016; 48: 1520-1521
Year: 2016
Opioids in COPD: a cause of death or a marker of illness severity?
Source: Eur Respir J 2016; 48: 1521-1522
Year: 2016
Fooling the brain to alleviate dyspnoea
Source: Eur Respir J, 50 (2) 1701383; 10.1183/13993003.01383-2017
Year: 2017
New inhaler devices: the good, the bad, and the ugly
Source: International Congress 2015 – Inhaled drugs: within and beyond the lungs
Year: 2015
Deprescribing of inhaled corticosteroids in patients with COPD with mild or moderate airflow limitation: what do patients think?
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Difficult-to-wean patients: can we avoid the problem?
Source: ERS Skills Course 2016
Year: 2016
A case of unexplained dyspnoea: when lung function testing matters!
Source: Breathe, 14 (4) 325; 10.1183/20734735.025018
Year: 2018
Treating non-adherence: the rest is pointless if the drugs stay in the cupboard!
Source: International Congress 2017 – Cystic fibrosis in children and adults: treatment dilemmas
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept